P1.08D.01 The Efficacy of Durvalumab after Concurrent Chemoradiotherapy for EGFR-Mutated Stage III Non-Small Cell Lung Cancer (NEJ063)

Saved in:

Bibliographic Details
Published in	Journal of thoracic oncology Vol. 19; no. 10; pp. S182 - S183
Main Authors	Kida, G., Fujisaki, T., Miyauchi, E., Kikuchi, H., Hommura, F., Yokoo, K., Tanaka, H., Kikuchi, T., Jingu, D., Sugisaka, J., Watanabe, K., Yoshimura, N., Nakagawa, T., Nogawa, H., Sato, M., Nakazawa, K., Soda, S., Takigami, A., Arai, D., Masubuchi, K., Miura, Y., Nagai, Y., Matsumoto, N., Oba, T., Namba, Y., Ashinuma, H., Saito, G., Kamimura, M., Takahashi, S., Isobe, K., Miyawaki, T., Nishiyama, K., Sakashita, H., Nozaki, K., Inomata, M., Umeda, Y., Tateishi, K., Tetsumoto, S., Tamiya, M., Tsubata, Y., Masuda, K., Obata, H., Yamaji, Y., Harada, M., Ohnishi, H., Nakao, A., Morita, S., Maemondo, M.
Format	Journal Article
Language	English
Published	Elsevier Inc 01.10.2024
Online Access	Get full text

Loading…

More Information
ISSN:	1556-0864
DOI:	10.1016/j.jtho.2024.09.332